The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment

• Published in: International journal of environmental research and public health Vol. 19; no. 7; p. 4166
• Main Authors: Calabrò, Giovanna Elisa, Boccalini, Sara, Panatto, Donatella, Rizzo, Caterina, Di Pietro, Maria Luisa, Abreha, Fasika Molla, Ajelli, Marco, Amicizia, Daniela, Bechini, Angela, Giacchetta, Irene, Lai, Piero Luigi, Merler, Stefano, Primieri, Chiara, Trentini, Filippo, Violi, Sara, Bonanni, Paolo, de Waure, Chiara
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 31.03.2022; MDPI
• Subjects: Adjuvants, Immunologic; Age groups; Aged; Chronic illnesses; Cost-Benefit Analysis; Costs; Decision making; Epidemics; Epidemiology; Ethics; Health surveillance; Health technology assessment; Humans; Infections; Influenza; Influenza Vaccines; Influenza, Human - prevention & control; Laboratories; Mortality; Older people; Population; Seasons; Systematic review; Technology Assessment, Biomedical; Vaccination; Vaccines; Italy; influenza; quadrivalent adjuvanted influenza vaccine; HTA; vaccines; Health Technology Assessment; elderly; vaccination

Background. The elderly, commonly defined as subjects aged ≥65 years, are among the at-risk subjects recommended for annual influenza vaccination in European countries. Currently, two new vaccines are available for this population: the MF59-adjuvanted quadrivalent influenza vaccine (aQIV) and the hi...